Sign In

Ryan Heit

Co-Founder and Vice President of Operations at Pacylex Pharmaceuticals

Ryan Heit is a seasoned professional with a diverse background in research, technology commercialization, business development, and angel investing.

With over a decade of experience in the angel investing space, Ryan has co-founded and invested in Valhalla Private Capital, showcasing his expertise in financing early stage companies.

Ryan has provided strategic business planning and company development for numerous early-stage, technology-based ventures in health-related fields during his tenure as the Director of the Merck Invention Accelerator and as an independent consultant.

Having served as the COO of Pacylex Pharmaceuticals, Ryan currently plays a pivotal role in driving operational excellence in the pharmaceutical industry.

Ryan's educational background includes a Master of Business Administration in Technology Commercialization, an MSc in Experimental Oncology, and a BSc in Biochemistry and Cell Biology, all from the University of Alberta.

Throughout his career, Ryan has held various key positions such as Co-Founder and Vice President of Operations at Pacylex Pharmaceuticals, Director at World in Need, and University of Alberta PSI Executive-in-Residence.

His affiliations with organizations like the Merck Invention Accelerator, Valhalla Private Capital, TEC Edmonton, and others highlight his wide-ranging expertise and involvement in the business and research landscapes.

Highlights

Apr 22 · linkedin

Nanostics announced today plans to develop a simple blood test to predict severe COVID-19 in SARS-CoV-2 patients, using their ClarityDX diagnostic platform. Nanostics will collaborate with the Canadian BioSample Repository in Alberta, and Century Clinical Research Inc. in Florida, to recruit COVID-19 patients to validate this novel test. ClarityDX COVID-19 test is forecasted to be ready for clinical validation studies in 6 to 8 weeks.

https://lnkd.in/gurwt9B

#COVID19 #COVID19Testing #Biotechnology

Nov 16 · linkedin

Please help me get the word out: The Merck Invention Accelerator is looking for our next cohort of applicants. We're looking for early-stage Canadian human and animal therapeutic companies to enter the program. Companies get access to Merck experts, capital and space. Details in the attached document. Please share!

Ryan Heit
Add to my network

Location

Edmonton, Alberta, Canada